This site is supported by
Community-Acquired Pneumonia (CAP) is a common disease that is associated with considerable mortality and morbidity, and accounts for high antibiotic consumption.1 Among adults in industrialized countries, pneumococcal pneumonia still accounts for at least 30% of all cases of community-acquired pneumonia admitted to the hospital, with a case fatality rate of 11% to 44%.2
Although numerous pathogens can cause CAP, Streptococcus pneumoniae remains the leading bacterial cause worldwide and the leading cause of mortality. It is also the most likely pathogen in patients with CAP admitted to the ICU.3
- Oosterheert, J. et al. (2005) Predicted effects on antibiotic use following the introduction of British or North American guidelines for community-acquired pneumonia in The Netherlands. Clin Microbiol Infect. 11(12):992-8.
- World Health Organization (WHO) (2009) Acute Respiratory Infections: Streptococcus pneumoniae. [Online] Available from: http://www.who.int/vaccine_research/diseases/ari/en/index3.html Accessed: 08 Mar 13
- Chiou, C. and Lu, V.L. (2006) Severe pneumococcal pneumonia: new strategies for management. Current Opinion in Critical Care, 12:000–000.